Compare Cadila Healthcare with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ABBOTT INDIA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ABBOTT INDIA CADILA HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 30.2 56.4 53.6% View Chart
P/BV x 3.6 16.7 21.7% View Chart
Dividend Yield % 1.0 0.4 231.3%  

Financials

 CADILA HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
ABBOTT INDIA
Mar-19
CADILA HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs4328,834 4.9%   
Low Rs3065,458 5.6%   
Sales per share (Unadj.) Rs128.61,731.1 7.4%  
Earnings per share (Unadj.) Rs18.5211.9 8.8%  
Cash flow per share (Unadj.) Rs24.4219.9 11.1%  
Dividends per share (Unadj.) Rs3.5065.00 5.4%  
Dividend yield (eoy) %0.90.9 104.2%  
Book value per share (Unadj.) Rs101.5945.2 10.7%  
Shares outstanding (eoy) m1,023.7421.25 4,817.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.94.1 69.6%   
Avg P/E ratio x19.933.7 59.1%  
P/CF ratio (eoy) x15.132.5 46.6%  
Price / Book Value ratio x3.67.6 48.2%  
Dividend payout %18.930.7 61.5%   
Avg Mkt Cap Rs m378,170151,848 249.0%   
No. of employees `00012.43.5 356.9%   
Total wages/salary Rs m21,2414,356 487.6%   
Avg. sales/employee Rs Th10,585.010,555.5 100.3%   
Avg. wages/employee Rs Th1,707.81,249.9 136.6%   
Avg. net profit/employee Rs Th1,526.51,292.2 118.1%   
INCOME DATA
Net Sales Rs m131,65636,786 357.9%  
Other income Rs m2,0111,133 177.5%   
Total revenues Rs m133,66737,919 352.5%   
Gross profit Rs m29,7316,047 491.6%  
Depreciation Rs m5,986169 3,537.8%   
Interest Rs m1,93523 8,600.0%   
Profit before tax Rs m23,8216,989 340.9%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,3032,485 213.4%   
Profit after tax Rs m18,9874,503 421.6%  
Gross profit margin %22.616.4 137.4%  
Effective tax rate %22.335.6 62.6%   
Net profit margin %14.412.2 117.8%  
BALANCE SHEET DATA
Current assets Rs m84,98127,610 307.8%   
Current liabilities Rs m73,4258,569 856.9%   
Net working cap to sales %8.851.8 17.0%  
Current ratio x1.23.2 35.9%  
Inventory Days Days7560 123.8%  
Debtors Days Days11027 399.8%  
Net fixed assets Rs m133,4931,057 12,630.7%   
Share capital Rs m1,024213 481.9%   
"Free" reserves Rs m102,83919,873 517.5%   
Net worth Rs m103,86320,086 517.1%   
Long term debt Rs m39,4970-   
Total assets Rs m234,83129,409 798.5%  
Interest coverage x13.3311.6 4.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.61.3 44.8%   
Return on assets %8.915.4 57.9%  
Return on equity %18.322.4 81.5%  
Return on capital %18.334.9 52.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,404369 13,119.0%   
Fx outflow Rs m11,5934,918 235.7%   
Net fx Rs m36,811-4,549 -809.1%   
CASH FLOW
From Operations Rs m28,8234,991 577.5%  
From Investments Rs m-57,387-2,570 2,233.0%  
From Financial Activity Rs m18,846-1,428 -1,319.7%  
Net Cashflow Rs m-7,105993 -715.3%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.3 7.9 105.1%  
FIIs % 5.9 0.1 5,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.1 64.3%  
Shareholders   44,069 18,270 241.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Power and Energy Stocks Drag(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.9% while the Hang Seng is down 0.3%. The Nikkei 225 is trading down by 0.6%.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 7, 2020 10:33 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS